Newcastle centre gains licence for therapeutic cloning
BMJ 2004; 329 doi: https://doi.org/10.1136/bmj.329.7463.417 (Published 19 August 2004) Cite this as: BMJ 2004;329:417- Stephen Pincock
- London
The United Kingdom has granted its first licence for researchers to create human embryonic stem cells by means of cell nuclear transfer, otherwise known as therapeutic cloning, prompting excitement among scientists—and anger among pro-life groups.
The Human Fertilisation and Embryology Authority (HFEA) granted the licence on 11 August to Professor Alison Murdoch and Dr Miodrag Stojkovic at the Newcastle Centre for Life, who will use the stem cells they generate to research diabetes, among other diseases.
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.